Lisa G. Rider is a pediatric rheumatologist and the Deputy Chief of the Environmental Autoimmunity Group of the Office of Clinical Research, in the National Institute of Environmental Health Sciences. She has conducted clinical and translational studies on pediatric autoimmune diseases, particularly focusing on the juvenile idiopathic inflammatory myopathies for more than 16 years. Dr. Rider obtained her B.S. and M.D. degrees from Duke University, NC, USA, completed her pediatric residency at the Children’s Hospital/University of Washington in Seattle, and completed fellowship training in pediatric rheumatology at Children’s National Medical Center and in NIAMS in a postdoctoral research fellowship with Dr. Henry Metzger. She joined Dr. Frederick Miller in a second postdoctoral fellowship in the Center for Biologics Evaluation and Research, later becoming a staff scientist in the group. She has served as a principal investigator of a large multicenter study of juvenile idiopathic inflammatory myopathies: the Childhood Myositis Heterogeneity Study, which has been defining autoantibody subsets, immunogenetic and environmental risk factors, and clinical prognostic factors for juvenile myositis. She also cochaired an international consortium of myositis researchers, the International Myositis Assessment and Clinical Studies Group (IMACS), which has developed and validated novel measures to assess disease activity in patients with myositis and is conducting other clinical research studies. She is a coinvestigator and a member of the steering committee of an NIH trial of rituximab for adult and juvenile dermato- and polymyositis. She has published more than 100 peer-reviewed manuscripts, reviews, and book chapters, serves as an advisor to several collaborative pediatric rheumatology research networks, and has been a medical advisor to myositis patient support groups.
Biography Updated on 6 April 2010